Home
>
National Drug Code (NDC)
>
Zaleplon
Zaleplon - 16714-551-02 - (Zaleplon)
Drug Information of Zaleplon
| Product NDC: | 16714-551 |
| Proprietary Name: | Zaleplon |
| Non Proprietary Name: | Zaleplon |
| Active Ingredient(s): | 5 mg/1 & nbsp; Zaleplon |
| Administration Route(s): | ORAL |
| Dosage Form(s): | CAPSULE |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Zaleplon
| Product NDC: | 16714-551 |
| Labeler Name: | Northstar Rx LLC |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA090374 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20100623 |
Package Information of Zaleplon
| Package NDC: | 16714-551-02 |
| Package Description: | 100 CAPSULE in 1 BOTTLE (16714-551-02) |
NDC Information of Zaleplon
| NDC Code | 16714-551-02 |
| Proprietary Name | Zaleplon |
| Package Description | 100 CAPSULE in 1 BOTTLE (16714-551-02) |
| Product NDC | 16714-551 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Zaleplon |
| Dosage Form Name | CAPSULE |
| Route Name | ORAL |
| Start Marketing Date | 20100623 |
| Marketing Category Name | ANDA |
| Labeler Name | Northstar Rx LLC |
| Substance Name | ZALEPLON |
| Strength Number | 5 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | gamma-Aminobutyric Acid A Receptor Agonist [EPC],GABA A Agonists [MoA],Central Nervous System Depression [PE] |
